Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/HspE7> ?p ?o }
Showing triples 1 to 54 of
54
with 100 triples per page.
- HspE7 abstract "HspE7 is an investigational therapeutic vaccine candidate being developed by Nventa Biopharmaceuticals for the treatment of precancerous and cancerous lesions caused by the human papillomavirus (HPV). HspE7 uses recombinant DNA technology to covalently fuse a heat shock protein (Hsp) to a target antigen, thereby stimulating cellular immune system responses to specific diseases. HspE7 is a patented construct consisting of the HPV Type 16 E7 protein and heat shock protein 65 (Hsp65) and is currently the only candidate using Hsp technology to target the over 20 million Americans already infected with HPV.The candidate is being developed with a Toll-like receptor 3 (TLR3) agonist adjuvant for multiple indications, including cervical intraepithelial neoplasia (also known as cervical dysplasia or CIN), genital warts, cervical cancer, and head and neck cancers.".
- HspE7 thumbnail HspE7_Construct.gif?width=300.
- HspE7 wikiPageID "18438094".
- HspE7 wikiPageLength "8497".
- HspE7 wikiPageOutDegree "36".
- HspE7 wikiPageRevisionID "672939937".
- HspE7 wikiPageWikiLink Agonist.
- HspE7 wikiPageWikiLink American_Cancer_Society.
- HspE7 wikiPageWikiLink Anal_cancer.
- HspE7 wikiPageWikiLink Antigen.
- HspE7 wikiPageWikiLink Cancer.
- HspE7 wikiPageWikiLink Category:Papillomavirus.
- HspE7 wikiPageWikiLink Category:Vaccines.
- HspE7 wikiPageWikiLink Cervarix.
- HspE7 wikiPageWikiLink Cervical_cancer.
- HspE7 wikiPageWikiLink Cervical_intraepithelial_neoplasia.
- HspE7 wikiPageWikiLink Covalent_bond.
- HspE7 wikiPageWikiLink Food_and_Drug_Administration.
- HspE7 wikiPageWikiLink Gardasil.
- HspE7 wikiPageWikiLink Genital_wart.
- HspE7 wikiPageWikiLink HPV_vaccines.
- HspE7 wikiPageWikiLink Head_and_neck_cancer.
- HspE7 wikiPageWikiLink Heat_shock_protein.
- HspE7 wikiPageWikiLink Human_papillomavirus.
- HspE7 wikiPageWikiLink Immunologic_adjuvant.
- HspE7 wikiPageWikiLink Innate_immune_system.
- HspE7 wikiPageWikiLink Laryngeal_papillomatosis.
- HspE7 wikiPageWikiLink Lesion.
- HspE7 wikiPageWikiLink Malignancy.
- HspE7 wikiPageWikiLink Nventa_Biopharmaceuticals_Corporation.
- HspE7 wikiPageWikiLink Oncogene.
- HspE7 wikiPageWikiLink Pap_test.
- HspE7 wikiPageWikiLink Penile_cancer.
- HspE7 wikiPageWikiLink Precancerous_condition.
- HspE7 wikiPageWikiLink Recombinant_DNA.
- HspE7 wikiPageWikiLink TLR3.
- HspE7 wikiPageWikiLink Vaccine.
- HspE7 wikiPageWikiLink Vulvar_cancer.
- HspE7 wikiPageWikiLink File:HspE7_Construct.gif.
- HspE7 wikiPageWikiLinkText "HspE7".
- HspE7 subject Category:Papillomavirus.
- HspE7 subject Category:Vaccines.
- HspE7 hypernym Candidate.
- HspE7 type Drug.
- HspE7 type Person.
- HspE7 type Drug.
- HspE7 comment "HspE7 is an investigational therapeutic vaccine candidate being developed by Nventa Biopharmaceuticals for the treatment of precancerous and cancerous lesions caused by the human papillomavirus (HPV). HspE7 uses recombinant DNA technology to covalently fuse a heat shock protein (Hsp) to a target antigen, thereby stimulating cellular immune system responses to specific diseases.".
- HspE7 label "HspE7".
- HspE7 sameAs Q17151936.
- HspE7 sameAs m.04f4kyg.
- HspE7 sameAs Q17151936.
- HspE7 wasDerivedFrom HspE7?oldid=672939937.
- HspE7 depiction HspE7_Construct.gif.
- HspE7 isPrimaryTopicOf HspE7.